0001193125-22-241003.txt : 20220908 0001193125-22-241003.hdr.sgml : 20220908 20220908160649 ACCESSION NUMBER: 0001193125-22-241003 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nuveen Global Cities REIT, Inc. CENTRAL INDEX KEY: 0001711799 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 821419222 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-252077 FILM NUMBER: 221233902 BUSINESS ADDRESS: STREET 1: 730 THIRD AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-490-9000 MAIL ADDRESS: STREET 1: 730 THIRD AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 424B3 1 d397065d424b3.htm 424B3 424B3

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-252077

NUVEEN GLOBAL CITIES REIT, INC.

SUPPLEMENT NO. 6 DATED SEPTEMBER 8, 2022

TO THE PROSPECTUS DATED MAY 27, 2022

This prospectus supplement (the “Supplement”) is part of and should be read in conjunction with the prospectus of Nuveen Global Cities REIT, Inc., dated May 27, 2022 (the “Prospectus”). Unless otherwise defined herein, capitalized terms used in this Supplement shall have the same meanings as in the Prospectus.

The purpose of this Supplement is to disclose the acquisition of a medical office portfolio.

Acquisition of a Medical Office Portfolio

We recently acquired a 100% interest in a 10-building medical office portfolio located in Atlanta, GA, Pittsburgh, PA, Tampa, FL, and Dallas, TX for an aggregate purchase price of approximately $300 million. The 661,000 square-foot portfolio consists of high-quality, newly-constructed or newly-renovated assets that were 96% leased at acquisition with a granular rent roll of 57 tenants, over 55% of which are rated investment-grade. The portfolio has in-place average annual escalations over 2.5%, a 5.7 year weighted average lease term and predominantly high-acuity use with significant capital invested in tenant buildout.

 

VGN-NREIT2-0922P